Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0368120040340080789
Korean Circulation Journal
2004 Volume.34 No. 8 p.789 ~ p.794
Long-term Follow-up Results of Tilt Training in Patients with Neurocardiogenic Syncope
±èÁ¦»ó/Kim JS
±èÁؼö/±è¼ºÇØ/¹é°æ±â/À̼±¹Ì/¹ÚÁ¤¿Ö/ÃÖÁøÈ£/¼ºÁöµ¿/ÀÌ»óö/¹Ú½Â¿ì/±ÇÇöö/ÀüÀº¼®/±è´ö°æ/ÀÌ»óÈÆ/È«°æÇ¥/¹ÚÁ¤ÀÇ/Kim JS/KIm SH/Beak KK/Lee SM/Park JW/Choi JH/Sung JD/Lee SC/Park SW/Gwon HC/Chun ES/Kim DK/Lee SH/Hong KP/Park JE
Abstract
Background and Objectives£ºTilt training as a non pharmacological therapy was recently introduced to treat the patients with neurocardiogenic syncope. Tilt training has been known to prevent neurocardiogenic syncope by desensitizing abnormal autonomic reflex. Herein, the early effect of tilt training and the preventive effect on the relapse of syncope were studied during a long-term follow-up period.

Subjects and Methods£ºFifteen patients (11 males) who experienced recurrent syncope, despite drug treatment or were intolerant to drug treatment, among those diagnosed as neurocardiogenic syncope by the head-up tilt test at Samsung Medical Center between March 2000 and May 2003 were recruited. Each patient underwent tilt training after admission and was educated to continue self-tilt training after discharge. Data for recurrences after discharge were obtained via questionnaires on outpatient visits or by telephone interviews.

Results£ºEleven (73%) of the 15 who underwent tilt training on admission showed therapeutic effects. The mean follow-up period was 21¡¾10 months (5-40 months). Only one patient was excluded due to follow-up loss. Ten of the above patients underwent training by themselves for an average of 4 months after discharge, and experience no relapse of syncope during the follow-up period.

Conclusion£ºTilt training maintained its therapeutic effect during long-term follow-up. This could be a new treatment for patients non responsive or intolerant to medical therapy.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø